Stock·NASDAQ·Financial Services
CleanSpark, Inc. (CLSK)
- Market cap
- $2.00B
- Dividend yield
- None
- Street target
- $23.50median of 14 analysts
- 52-week range
- $7.36 $20.87
CLSK stock forecast today
Where CLSK stands today, and what CleaRank Financial AI makes of it.
CLSK at a glance
CleanSpark, Inc. (CLSK): Sell, 25/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($11.85 and $12.43).
- Earnings CLSK beat estimates in 2 of its last 7 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $3.0M and made no open-market purchases over the last 18 months.
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates CleanSpark, Inc. (CLSK) Sell, with a model score of 25/100.
The analysts' outlook lifts the score most: 14 of 14 analysts rate it a buy and the median target is 202.4% above the price. The trend holds it back most: the price is 37.48% below its 200-day average and 34.43% below its 50-day average, and the 50-day average is 4.65% below the 200-day. The 50-day average stands at $11.85 and the 200-day at $12.43. Over the past year the price fell 59.88%.
Only on CleaRank
Figures we compute ourselves from CLSK's own price, earnings and insider-filing history. Tap one to see it in context.
CLSK stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $7.77 is 34.4% below the 50-day simple moving average of $11.85.Price above its 200-day average ›
The price is 37.5% below the 200-day simple moving average of $12.43.50-day average above the 200-day ›
The 50-day average ($11.85) is 4.7% below the 200-day average ($12.43), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 3% of its 52-week range, between $7.36 and $20.87.
CLSK share price
Pick a period: each tab shows how far CLSK has moved over it, to the last close.
Today's trading
Where CLSK sits inside today's range and its 52-week range.
CLSK fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/S below the sector median ›
The price-to-sales ratio of 2.94 is 22.7% below the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was -$1.0B on revenue of $679.2M, a net margin of -151.4%.Beat estimates in most recent reports ›
CLSK beat the EPS estimate in 2 of its last 7 reports.
Key statistics
The headline figures for CLSK.
As of October 26, 2026, CLSK trades at $7.77, with a market value of $2.00B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of CLSK's valuation, growth and risks.
CleanSpark, Inc. (CLSK) has no meaningful P/E, because its earnings per share over the last 12 months are negative. The P/S stands at 2.94, against a sector median of 3.8; that places it 22.7% below the sector median P/S. Trailing earnings are -$3.78 a share.
The company is losing money, with a net margin of -151.4% and an operating margin of -165.19%, and a return on equity of -68.62%, below the sector median of 13.8%. In the latest quarter, against the same quarter a year earlier, revenue fell 30.50%, 42.2 percentage points slower than the sector median of 11.7%. Debt-to-equity of 2.35 rounds out the fundamentals.
CLSK's latest report, dated August 6, 2026, showed EPS of -$0.39 a share, short of the -$0.33 analysts had estimated. That was a worse result than expected, and the shares dropped 3.53% in the following session.
Over its last 7 reports, CLSK topped the estimate 2 times; even so, 1 of those 2 beats was followed by a lower share price the next session. Earlier, the stock rose 21.96% after the February 5, 2026 report, a miss of 728.57%. Looking ahead, analysts expect EPS of -$2.19 this fiscal year and -$1.81 the year after.
The 30-day standard deviation of CLSK's daily returns is 4.04%; measured against the S&P 500, its beta is 3.84. The downtrend is itself a risk for as long as the price stays under both moving averages. The price is 62.76% below its 52-week high of $20.87. Over the last 18 months, insider sales totalled $3.0M with no open-market purchases; planned sales and tax sales on vesting shares make selling a weaker signal than buying.
CLSK against the Bitcoin Mining sector
How CLSK compares with the median Bitcoin Mining stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, CLSK trades at 2.94x, -23% versus the sector average of 3.80x.
Return vs BITQ: Since May 14, 2025, CLSK has lost 19.2% against a gain of 9.9% for BITQ.
Performance against BITQ
CLSK and the Bitcoin Mining sector fund over the same days.
Revenue and earnings
How much CLSK sells, and how much of it becomes profit.
Revenue growth: Revenue grew 102.2% in FY2025 to $766M, from $379M a year earlier.
Profit margin: The net margin was 47.6% in FY2025, up from -38.5% the year before.
Profitable: CLSK earned $364M in FY2025.
Earnings reality check
Did CLSK beat what analysts expected, and how did the stock react?
Earnings record: CLSK beat the analyst estimate in 2 of the last 7 quarters.
Market reaction: The stock fell in the first session after 1 of those 2 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 6, 2026after close | -$0.33 | -$0.39 | -18.18% | -3.53% | -9.65% |
| May 11, 2026after close | -$0.23 | -$0.49 | -113.04% | -5.80% | -6.01% |
| Feb 5, 2026after close | $0.21 | -$1.32 | -728.57% | +21.96% | +12.64% |
| Nov 25, 2025after close | $0.54 | $0.16 | -70.37% | +13.79% | +22.59% |
| May 8, 2025after close | $0.08 | -$0.48 | -700.00% | +5.99% | +7.83% |
| Feb 6, 2025after close | -$0.16 | $0.80 | +600.00% | +9.15% | +2.79% |
| Dec 2, 2024after close | -$0.16 | $0.28 | +275.00% | -3.93% | -6.61% |
As of October 26, 2026, CLSK has beaten the analyst EPS estimate in 2 of its last 7 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on August 6, 2026, came in 18.18% below the estimate and the stock moved -3.53% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
CLSK AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 23.7, in oversold territory.RSI above 50 ›
An RSI of 23.7 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of CLSK
The score, the reasoning behind it, and what could move the price next.
CleanSpark, Inc. (CLSK) is in a downtrend: both of its moving averages sit above the price. At $7.77, the stock is 34.43% below its 50-day average of $11.85 and 37.48% below its 200-day average of $12.43. The price sits at 3% of its 52-week range, 5.57% above the 52-week low of $7.36. The two averages agree with this picture, since the 50-day is 4.65% below the 200-day.
On momentum, the 14-day RSI reads 23.7, in oversold territory, with the MACD line negative. The recent returns all show a loss, with the price down 44.60% over the past three months, 36.57% over the past six months and 59.88% over the past year.
Rating reaffirmed ›
Cantor Fitzgerald kept its Overweight rating on October 16, 2026.
Source: Analyst action, Cantor Fitzgerald, October 16, 2026
Earnings miss ›
The August 6, 2026 report missed the EPS estimate by 18.18%, and the share price fell 3.53% in the first session after it.
Source: Earnings report, August 6, 2026
- Two levels matter most: the 20-day EMA at $9.89, which sits above the price, and the 52-week low at $7.36, which sits below it.
- The 14-day RSI is 23.7, which is in the oversold zone, and the MACD line is negative. Readings above 70 or below 30 point to stretched momentum.
- The share price dropped 3.53% in the first session after the August 6, 2026 report. Over the last 7 reports, CLSK beat estimates in 2.
While CLSK trades below its 50-day average of $11.85 and its 200-day average of $12.43, the downtrend remains intact. A close back above the 50-day average would be the first sign of a repair. The 20-day EMA, at $9.89, is the first hurdle above the price.
The next level below the price is the 52-week low of $7.36. The RSI reads in oversold territory, so a recovery above the oversold line would be the first hint that selling pressure is easing.
Technical indicators
Momentum and trend for CLSK, from its daily closes.
As of October 26, 2026, with CLSK at $7.77, its 14-day RSI is 23.7 (oversold territory), its 50-day simple moving average is $11.85 and its 200-day is $12.43.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What CLSK moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, CLSK's 1-year correlation of daily returns is +0.48 with S&P 500 (SPY), +0.51 with Nasdaq 100 (QQQ), +0.60 with Bitcoin (BTC) and +0.24 with gold (XAU).
CLSK price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
14 of 14 analysts rate it a buy or strong buy, 0 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $23.50 is 202.4% above the price.More buy ratings than three months ago ›
14 of 14 rate it a buy now, against 13 of 13 three months ago.
CLSK Wall Street View
12-month price targets
The price, $7.77, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 16, 2026 | Cantor Fitzgerald | Maintains | Overweight |
| Aug 10, 2026 | Chardan Capital | Maintains | Buy |
| Aug 7, 2026 | Cantor Fitzgerald | Reiterates | Overweight |
| Aug 3, 2026 | B. Riley Securities | Maintains | Buy |
| Jul 28, 2026 | Keefe, Bruyette & Woods | Maintains | Outperform |
| Jul 28, 2026 | Chardan Capital | Maintains | Buy |
As of October 26, 2026, 14 Wall Street analysts cover CLSK: 14 rate it a buy or strong buy, 0 a hold and 0 a sell or strong sell. Their 12-month price targets range from $19.00 to $27.00. The median CLSK price target is $23.50, 202.4% above the price of $7.77.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
CLSK trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CLSK trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
CLSK moves about 4.0% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CLSK tends to move, against the market and on its own.
CLSK price history and drawdowns
CLSK's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 4.04% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 98.3%, from September 2018 to April 2020; the price is still 88.0% below that peak.Most 1-year holds ended higher ›
45% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in November 2016 is now worth $2,242, against $41,109 in the S&P 500 (SPY).
CLSK Drawdowns & Recovery
As of October 26, 2026, CLSK's worst peak-to-trough fall over the last 10 years with dividends reinvested was -98.3% (September 2018 to April 2020); it is still 88.0% below that peak, and 45% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CLSK in November 2016 is worth now, against the same amount in the S&P 500.
Against the market: CLSK trailed the S&P 500 over this period: $2,241.93 against $41,109.
A $10,000 investment in CLSK in November 2016 would be worth about $2,242 today with dividends reinvested, compared with about $41,109 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CLSK, and which have not.
Strongest month, July: an average of +25.56%, up in 4 of 10 years.
Weakest month, March: an average of -7.53%, up in 3 of 10 years.
This month, October: has averaged -0.40%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CLSK's strongest calendar month has been July (average +25.56%, up in 4 of 10 years) and its weakest March (average -7.53%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
CLSK stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CLSK, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in CLSK today could grow to about $8,169 by 2030 in the base case, with a 90th-percentile outcome near $29,427 and a 10th-percentile outcome around $2,268. Projections are statistical simulations, not guarantees.
CLSK Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $6.35 for CLSK by 2030 in the base case, from $7.77 today (0.8x over 4 years). The 10th-percentile path ends near $1.76. These are outcomes of a Monte Carlo simulation run on CLSK's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $3.89 | $7.39 | $14.02 | |
| 2028 | $2.84 | $7.02 | $17.38 | |
| 2029 | $2.20 | $6.68 | $20.26 | |
| 2030 | $1.76 | $6.35 | $22.87 |
Method: a lognormal simulation of CLSK's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
CLSK insider trading
What the people running the company have bought and sold.
CLSK insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought CLSK shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, CLSK insiders reported 6 open-market sales worth $3.0M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Taylor Monnig
Chief Operating Officer
|
Sell | 29.8K | $393.7K |
| Sep 4, 2026 | Brian Jay Carson
Officer
|
Grant | 153.7K | - |
| Sep 4, 2026 | Scott Eugene Garrison
Officer
|
Grant | 297.6K | - |
| Sep 4, 2026 | Taylor Monnig
Chief Operating Officer
|
Grant | 297.6K | - |
| Sep 4, 2026 | Matthew Schultz
Chief Executive Officer
|
Grant | 1.0M | - |
| Sep 4, 2026 | Gary Anthony Vecchiarelli
President
|
Grant | 398.5K | - |
| Aug 14, 2026 | Taylor Monnig
Chief Operating Officer
|
Sell | 54 | $622 |
| Aug 13, 2026 | Scott Eugene Garrison
Officer
|
Grant | 2.7K | - |
| Aug 13, 2026 | Taylor Monnig
Chief Operating Officer
|
Grant | 536 | - |
| Aug 13, 2026 | Matthew Schultz
Chief Executive Officer
|
Grant | 20.5K | - |
| Aug 13, 2026 | Gary Anthony Vecchiarelli
President
|
Grant | 1.6K | - |
| Jun 30, 2026 | Roger Paul Beynon
Director
|
Grant | 7.8K | - |
| Jun 30, 2026 | Amanda Cavaleri
Director
|
Grant | 7.8K | - |
| Jun 30, 2026 | Larry R Mcneill
Director
|
Grant | 7.8K | - |
| Jun 30, 2026 | Thomas Leigh Wood
Director
|
Grant | 7.8K | - |
| May 13, 2026 | Scott Eugene Garrison
Officer
|
Grant | 2.7K | - |
| May 13, 2026 | Taylor Monnig
Chief Operating Officer
|
Grant | 535 | - |
| May 13, 2026 | Matthew Schultz
Chief Executive Officer
|
Grant | 20.5K | - |
| May 13, 2026 | Gary Anthony Vecchiarelli
President
|
Grant | 1.6K | - |
| Mar 31, 2026 | Roger Paul Beynon
Director
|
Grant | 7.4K | - |
| Mar 31, 2026 | Amanda Cavaleri
Director
|
Grant | 7.4K | - |
| Mar 31, 2026 | Larry R Mcneill
Director
|
Grant | 7.4K | - |
| Mar 31, 2026 | Thomas Leigh Wood
Director
|
Grant | 7.4K | - |
| Feb 13, 2026 | Brian Jay Carson
Officer
|
Grant | 16.4K | - |
| Feb 13, 2026 | Scott Eugene Garrison
Officer
|
Grant | 47.8K | - |
| Feb 13, 2026 | Taylor Monnig
Chief Operating Officer
|
Grant | 45.7K | - |
| Feb 13, 2026 | Matthew Schultz
Chief Executive Officer
|
Grant | 236.7K | - |
| Feb 13, 2026 | Gary Anthony Vecchiarelli
President
|
Grant | 71.2K | - |
| Dec 31, 2025 | Roger Paul Beynon
Director
|
Grant | 7.4K | - |
| Dec 31, 2025 | Amanda Cavaleri
Director
|
Grant | 7.4K | - |
| Dec 31, 2025 | Larry R Mcneill
Director
|
Grant | 7.4K | - |
| Dec 31, 2025 | Thomas Leigh Wood
Director
|
Grant | 7.4K | - |
| Dec 23, 2025 | Thomas Leigh Wood
Director
|
Sell | 85.3K | $997.1K |
| Dec 4, 2025 | Amanda Cavaleri
Director
|
Sell | 33.0K | $495.7K |
| Dec 3, 2025 | Roger Paul Beynon
Director
|
Grant | 8.5K | - |
| Dec 3, 2025 | Amanda Cavaleri
Director
|
Grant | 8.5K | - |
| Dec 3, 2025 | Scott Eugene Garrison
Officer
|
Grant | 2.7K | - |
| Dec 3, 2025 | Larry R Mcneill
Director
|
Grant | 8.5K | - |
| Dec 3, 2025 | Taylor Monnig
Chief Operating Officer
|
Grant | 536 | - |
| Dec 3, 2025 | Matthew Schultz
Chief Executive Officer
|
Grant | 20.5K | - |
| Dec 3, 2025 | Gary Anthony Vecchiarelli
President
|
Grant | 1.6K | - |
| Dec 3, 2025 | Thomas Leigh Wood
Director
|
Grant | 8.5K | - |
| Sep 30, 2025 | Scott Eugene Garrison
Officer
|
Grant | 33.4K | - |
| Sep 30, 2025 | Taylor Monnig
Chief Operating Officer
|
Grant | 33.4K | - |
| Sep 12, 2025 | Matthew Schultz
Chief Executive Officer
|
Grant | 405.0K | - |
| Sep 12, 2025 | Gary Anthony Vecchiarelli
President
|
Grant | 40.0K | - |
| Sep 9, 2025 | Taylor Monnig
Chief Operating Officer
|
Sell | 63.7K | $581.1K |
| Sep 9, 2025 | Brian Jay Carson
Officer
|
Grant | 32.8K | - |
| Sep 9, 2025 | Scott Eugene Garrison
Officer
|
Grant | 90.3K | - |
| Sep 9, 2025 | Taylor Monnig
Chief Operating Officer
|
Grant | 90.3K | - |
| Sep 9, 2025 | Matthew Schultz
Chief Executive Officer
|
Grant | 432.3K | - |
| Sep 9, 2025 | Gary Anthony Vecchiarelli
President
|
Grant | 139.3K | - |
| Aug 13, 2025 | Roger Paul Beynon
Director
|
Grant | 8.5K | - |
| Aug 13, 2025 | Amanda Cavaleri
Director
|
Grant | 8.5K | - |
| Aug 13, 2025 | Scott Eugene Garrison
Chief Operating Officer
|
Grant | 2.7K | - |
| Aug 13, 2025 | Larry R Mcneill
Director
|
Grant | 8.5K | - |
| Aug 13, 2025 | Taylor Monnig
Chief Technology Officer
|
Grant | 535 | - |
| Aug 13, 2025 | Matthew Schultz
Officer and Director
|
Grant | 20.5K | - |
| Aug 13, 2025 | Gary Anthony Vecchiarelli
Chief Financial Officer
|
Grant | 1.6K | - |
| Aug 13, 2025 | Thomas Leigh Wood
Director
|
Grant | 8.5K | - |
| Aug 8, 2025 | Zachary Bradford
Chief Executive Officer
|
Grant | 1.7M | - |
| May 21, 2025 | Roger Paul Beynon
Director
|
Sell | 50.0K | $525.3K |
Source: TwelveData, from SEC Form 4 filings
CLSK stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.